Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Regulatory

Coya Therapeutics Added to MSCI USA Micro Cap Index

  • The Pharma Data
  • May 29, 2024

A clinical-stage biotechnology company developing biologics to enhance regulatory T cell (Treg) function, Coya Therapeutics, has announced that MSCI has included its shares in the MSCI USA Micro Cap Index…

Read MoreCoya Therapeutics Added to MSCI USA Micro Cap Index
  • Press Releases

MEDSIR and Debiopharm Collaborate on Advanced Breast Cancer Treatment

  • The Pharma Data
  • May 29, 2024

Integrated Biosciences, a biotechnology company leveraging synthetic biology and machine learning to create next-generation therapeutics for age-related diseases, announced its collaboration with Illumina Ventures Labs. This partnership aims to integrate…

Read MoreMEDSIR and Debiopharm Collaborate on Advanced Breast Cancer Treatment
  • Regulatory

Sarclisa Receives FDA Priority Review for Treating Newly Diagnosed Multiple Myeloma

  • The Pharma Data
  • May 28, 2024

The U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for Sarclisa (isatuximab) for Priority Review. The application is for the investigational use of Sarclisa…

Read MoreSarclisa Receives FDA Priority Review for Treating Newly Diagnosed Multiple Myeloma
  • News

Coming Full Circle: From Curiosity About Life on Earth to Transformative Therapies at Novartis

  • The Pharma Data
  • May 28, 2024

A Journey from Curiosity About Life on Earth to Transformative Therapies at Novartis When I was young, my fascination with science began with the natural world and animals. A BBC…

Read MoreComing Full Circle: From Curiosity About Life on Earth to Transformative Therapies at Novartis
  • Regulatory

Datopotamab Deruxtecan Improves Survival in Advanced Non-Squamous NSCLC: TROPION-Lung01 Phase III Results

  • The Pharma Data
  • May 28, 2024

High-level overall survival (OS) results from the TROPION-Lung01 Phase III trial, which previously met the primary endpoint of progression-free survival (PFS), numerically favored datopotamab deruxtecan (Dato-DXd) over docetaxel in patients…

Read MoreDatopotamab Deruxtecan Improves Survival in Advanced Non-Squamous NSCLC: TROPION-Lung01 Phase III Results
  • Press Releases

Updates to Roche’s Expanded Corporate Executive Committee

  • The Pharma Data
  • May 28, 2024

Roche announced today that James Sabry (born 1958), Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head…

Read MoreUpdates to Roche’s Expanded Corporate Executive Committee
  • News

BridgeBio Pharma to Share Further Insights on Acoramidis Study for Transthyretin Amyloid Cardiomyopathy at 2024 ISA Meeting

  • The Pharma Data
  • May 25, 2024

A biopharmaceutical company specializing in genetic diseases and cancers has unveiled plans to present a series of findings at the 2024 International Symposium on Amyloidosis (ISA) in Rochester, Minnesota, from…

Read MoreBridgeBio Pharma to Share Further Insights on Acoramidis Study for Transthyretin Amyloid Cardiomyopathy at 2024 ISA Meeting
  • Regulatory

Latest Findings: WAINUA (eplontersen) Study Results at 2024 ISA

  • The Pharma Data
  • May 25, 2024

Today, it was announced that new subgroup analyses from Ionis and AstraZeneca’s Phase 3 NEURO-TTRansform study of WAINUA™ (eplontersen) will be presented at the 2024 International Symposium on Amyloidosis (ISA)…

Read MoreLatest Findings: WAINUA (eplontersen) Study Results at 2024 ISA
  • Featured

WHO Member States to Share Historic IHR, Pandemic Agreement Outcomes at World Health Assembly

  • The Pharma Data
  • May 25, 2024

After intensive negotiations, WHO Member States have concluded discussions aimed at enhancing global readiness for future pandemics and outbreaks following the COVID-19 crisis. They have agreed to present the outcomes…

Read MoreWHO Member States to Share Historic IHR, Pandemic Agreement Outcomes at World Health Assembly
  • Research

Arrival of R21 Malaria Vaccine in Central African Republic: Advancing Child Survival

  • The Pharma Data
  • May 25, 2024

UNICEF has airlifted over 43,000 doses of the R21/Matrix-M malaria vaccine to Bangui, Central African Republic, marking a significant stride in combatting the disease and safeguarding children’s lives. This initial…

Read MoreArrival of R21 Malaria Vaccine in Central African Republic: Advancing Child Survival
  • News

WHO’s Framework to Improve MPOX Prevention and Control

  • The Pharma Data
  • May 25, 2024

Monkeypox, a viral disease, continues its global impact. Today, the World Health Organization (WHO) unveiled a new strategic framework aimed at guiding efforts to prevent and manage monkeypox outbreaks. The…

Read MoreWHO’s Framework to Improve MPOX Prevention and Control
  • News

COVID-19 Wipes Out Decade of Global Life Expectancy Gains

  • The Pharma Data
  • May 25, 2024

In the latest release of the World Health Statistics by the World Health Organization (WHO), the impact of the COVID-19 pandemic on global life expectancy and healthy life expectancy at…

Read MoreCOVID-19 Wipes Out Decade of Global Life Expectancy Gains
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany
Global Clinical

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Biogen to Acquire Apellis, Expanding Immunology and Rare Disease Portfolio and Entering Nephrology
  • Bristol Myers Squibb Marks a Decade of GAAP Progress, Expanding Efforts to Advance Equity in Multiple Myeloma Care
  • Lilly to Acquire Centessa Pharmaceuticals to Strengthen Pipeline in Sleep-Wake Disorder Treatments
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.